Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|August 20, 2021
Kinetics of Archived M184V Mutation in Treatment-Experienced Virally Suppressed HIV-Infected PatientsRomain Palich, Elisa Teyssou, Sophie Sayon, et al.
World Journal of Hepatology|September 2, 2015
Virological response and resistance mutations to NS3/4A inhibitors in hepatitis C virus-human immunodeficiency virus coinfectionAlissa Naqvi, Valérie Giordanengo, Brigitte Dunais, et al.
AIDS Research and Human Retroviruses|September 29, 2012
Long-term efficacy and safety of atazanavir/ritonavir treatment in a real-life cohort of treatment-experienced patients with HIV type 1 infectionKlaus Jansen, Anders Sönnerborg, Norbert Brockmeyer, et al.
Current HIV Research|April 18, 2013
Long-term gender-based outcomes for atazanavir/ritonavir (ATV/r)- containing regimens in treatment-experienced patients with HIVVeronica Svedhem-Johansson, Pascal Pugliese, Norbert H Brockmeyer, et al.
Medicine|October 15, 2016
First-line cART regimen impacts the course of CD8+ T-cell counts in HIV-infected patients that achieve sustained undetectable viral loadIsabelle Poizot-Martin, Clotilde Allavena, Cyrille Delpierre, et al.
Plos One|April 19, 2019
Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infectionPierre Gantner, Laurent Cotte, Clotilde Allavena, et al.
Infectious Diseases (London, England)|January 14, 2016
Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patientsClotilde Allavena, Christine Katlama, Laurent Cotte, et al.
Journal of the International AIDS Society|November 15, 2014
Efficacy and tolerability of Etravirine in HIV-1 adult patients: Results of a large French prospective cohortClotilde Allavena, Christine Katlama, Laurent Cotte, et al.
Pageof 9